Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cognition and eye movements: assessment of cerebral dysfunction.
Fluctuations of MS births and UV-light exposure.
Exome sequencing to find rare variants causing neurologic diseases.
Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
Update on multiple sclerosis treatments.
Lipid domains control myelin basic protein adsorption and membrane interactions between model myelin lipid bilayers.
Assessment of postural stabilization in three task oriented movements in people with multiple sclerosis.
Paroxysmal chorea as a relapse of myelopathy in a patient with neuromyelitis optica.
Alemtuzumab and multiple sclerosis: Is it safe?
Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination.
Accelerometry as a measure of walking behavior in multiple sclerosis.
The Effect of Contralateral Strength Training on Muscle Weakness in People With Multiple Sclerosis: A Proof-of-Concept Case Series.
Dalfampridine: A Medication to Improve Walking in Patients with Multiple Sclerosis (July/August).
Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling.
New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds.
The Incidence, Prevalence, Costs and Impact on Disability of Common Conditions Requiring Rehabilitation in the US: Stroke, Spinal Cord Injury, Traumatic Brain Injury, Multiple Sclerosis, Osteoarthritis, Rheumatoid Arthritis, Limb Loss, and Back Pain.
Hypomethylating Agent 5-Aza-2'-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models.
Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect?
Predicting short-term conversion from CIS to MS: Relevance of lesion distribution.
Improving the quality of mental health care in Multiple Sclerosis.
Low vitamin D level is associated with higher relapse rate in natalizumab treated MS patients.
Current and emerging therapies in multiple sclerosis: a systematic review.
Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS).
Pathogenesis of multiple sclerosis: what can we learn from the cuprizone model.
No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients.

Pages